SetPoint Medical looks to raise $20.5 million for pivotal trial

Retrieved on: 2019-09-18 03:06:10

Tags for this article:

Health sciences

Health

Medical research

Clinical pharmacology

Clinical research

Clinical trial

Design of experiments

Pharmaceutical industry

Pivotal trial

Food and Drug Administration

Click the tags to see associated articles and topics

SetPoint Medical looks to raise $20.5 million for pivotal trial. View article details on hiswai:

Excerpt

<div>Excluding the unidentified new investor, they are <b>Morgenthaler Ventures</b>, New Enterprise Associates, Topspin Partners, Medtronic, GlaxoSmithKline's ...</div>

Article found on:

View Original Article